399 related articles for article (PubMed ID: 25552581)
1. Human Clostridium difficile infection: altered mucus production and composition.
Engevik MA; Yacyshyn MB; Engevik KA; Wang J; Darien B; Hassett DJ; Yacyshyn BR; Worrell RT
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G510-24. PubMed ID: 25552581
[TBL] [Abstract][Full Text] [Related]
2. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.
Engevik MA; Engevik KA; Yacyshyn MB; Wang J; Hassett DJ; Darien B; Yacyshyn BR; Worrell RT
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G497-509. PubMed ID: 25552580
[TBL] [Abstract][Full Text] [Related]
3. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
4. Fecal transplant for recurrent Clostridium difficile infection.
Lofland D; Josephat F; Partin S
Clin Lab Sci; 2013; 26(3):131-5. PubMed ID: 23967542
[TBL] [Abstract][Full Text] [Related]
5. Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.
Weingarden AR; Dosa PI; DeWinter E; Steer CJ; Shaughnessy MK; Johnson JR; Khoruts A; Sadowsky MJ
PLoS One; 2016; 11(1):e0147210. PubMed ID: 26789728
[TBL] [Abstract][Full Text] [Related]
6. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.
Engevik MA; Danhof HA; Auchtung J; Endres BT; Ruan W; Bassères E; Engevik AC; Wu Q; Nicholson M; Luna RA; Garey KW; Crawford SE; Estes MK; Lux R; Yacyshyn MB; Yacyshyn B; Savidge T; Britton RA; Versalovic J
Gastroenterology; 2021 Mar; 160(4):1301-1314.e8. PubMed ID: 33227279
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
[TBL] [Abstract][Full Text] [Related]
8. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
9. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
[TBL] [Abstract][Full Text] [Related]
10. A case-control study of community-associated Clostridium difficile infection.
Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile and the disease it causes.
Norén T
Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile-associated polymorphonuclear neutrophil activation.
Olson A; Diebel LN; Liberati DM
Am J Surg; 2015 Mar; 209(3):493-7. PubMed ID: 25595713
[TBL] [Abstract][Full Text] [Related]
13. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
[TBL] [Abstract][Full Text] [Related]
14. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.
Johansson ME; Phillipson M; Petersson J; Velcich A; Holm L; Hansson GC
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15064-9. PubMed ID: 18806221
[TBL] [Abstract][Full Text] [Related]
15. In situ characterization of O-linked glycans of Muc2 in mouse colon.
Liquori GE; Mastrodonato M; Mentino D; Scillitani G; Desantis S; Portincasa P; Ferri D
Acta Histochem; 2012 Nov; 114(7):723-32. PubMed ID: 22261557
[TBL] [Abstract][Full Text] [Related]
16. Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model.
Geeraerts S; Ducatelle R; Haesebrouck F; Van Immerseel F
J Gastroenterol Hepatol; 2015 Aug; 30(8):1275-80. PubMed ID: 25800047
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
Kelly CR; de Leon L; Jasutkar N
J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
[TBL] [Abstract][Full Text] [Related]
18. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
Sethi AK; Al-Nassir WN; Nerandzic MM; Bobulsky GS; Donskey CJ
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):21-7. PubMed ID: 19929371
[TBL] [Abstract][Full Text] [Related]
19. Does Alkaline Colonic pH Predispose to Clostridium difficile Infection?
Gupta P; Yakubov S; Tin K; Zea D; Garankina O; Ghitan M; Chapnick EK; Homel P; Lin YS; Koegel MM
South Med J; 2016 Feb; 109(2):91-6. PubMed ID: 26840963
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis.
Saavedra PHV; Huang L; Ghazavi F; Kourula S; Vanden Berghe T; Takahashi N; Vandenabeele P; Lamkanfi M
Nat Commun; 2018 Nov; 9(1):4846. PubMed ID: 30451870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
